Prof Calliope Dendrou, alongside 2025 Nobel Prize Winner, aims to ‘stop the clock’ on chronic inflammation
9 October 2025
Teaming up with scientists and clinician-scientists at the University of Birmingham, and with 2025 Nobel Prize winner Professor Shimon Sakaguchi from Osaka University, Professor Calliope Dendrou from the Kennedy Institute will work on a major research programme to transform the treatment of autoimmune diseases by halting chronic inflammation at its source.
New research finds T cells linked to mild COVID-19 and future protection
2 October 2025
A new study, led by researchers at the CAMS Oxford Institute in the Nuffield Department of Medicine and TIDU in the MRC Weatherall Institute of Molecular Medicine, has found that dominant T cell responses years after infection are associated with mild COVID-19 disease, and likely play important protective roles to following viral infections.
New research reveals optimal time intervals for COVID-19 vaccine boosters
18 September 2025
Two new papers from University of Oxford scientists have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
Hashem Koohy receives Wellcome Discovery Award to decode T cell immunity
15 September 2025
Hashem Koohy, Associate Professor of Systems Immunology, has been awarded funding from Wellcome to develop computational strategies to decipher the underlying rules of adaptive T cell immunity.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia
3 September 2025
Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.
New studies reveal optimal time intervals for COVID-19 vaccine boosters
2 September 2025
Two new papers from scientists in the Nuffield Department of Medicine and other University of Oxford institutions have shown how the immune system reacts differently depending on the length of interval between vaccine doses.
Scientists create first atlas showing cell interaction in lung fibrosis
7 August 2025
In a collaborative new study, researchers have developed the first mathematically supported cellular map of lung tissue in idiopathic pulmonary fibrosis and uncovered key immune cell interactions that could explain why lungs fail to repair in this deadly disease with no known cure.
New Study Links Cancer Stage to Strength of Antitumoral Immune Response in HR+ Breast Cancer
29 July 2025
The latest study from Tao Dong's Group in the MRC Translational Immune Discovery Unit has been published in Cell Reports Medicine.
Immune cells show promise in treating hypertrophic cardiomyopathy
21 July 2025
A new study from scientists at the Radcliffe Department of Medicine and Harvard Medical School, and funded by the British Heart Foundation, has uncovered a potential new treatment for hypertrophic cardiomyopathy (HCM).
European Phagocyte Workshop 2026 - conference website now live
24 June 2025
The 2026 European Phagocyte Workshop will take place in the historic city of Oxford, UK, 23 – 25 March 2026. This popular conference series highlights the latest advances in phagocyte biology. With capacity to host up to 250 delegates, we will bring together researchers from across the globe, providing plenty of networking opportunities to encourage new connections and collaborations.
‘Dangerous Matter’: A New Opera on Vaccine Science, Memory, and Innovation
23 May 2025
The Thanks for the Memories public engagement programme are delighted to announce the next major event of their project: the premier of a new opera, ‘Dangerous Matter’, at the Royal Northern College of Music on June 24th, 2025, inspired by the story of Lady Mary Wortley Montagu and University of Oxford research into immune memory.
Coeliac disease may be driven by immune structures in the gut
7 May 2025
Researchers in the Nuffield Department of Medicine have found structures of immune cells in the gut that may be driving the response to gluten in people with coeliac disease. These findings could provide a target for future therapies.
TCRs drive CARs
1 May 2025
Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.
New episode of To Immunity and Beyond: Research with Human Tissue Samples on the International Space Station
1 May 2025
Ghada Alsaleh explains how research on human cells in space may uncover the hidden mechanisms behind ageing.
New Study Finds Common Virus May Improve Skin Cancer Treatment Outcomes
23 April 2025
A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.
Sooraj Achar wins the 2025 Peter Medawar Prize for Immunology
16 April 2025
The 2025 prize was awarded to Sooraj Achar (NCI/Kennedy Institute) for his outstanding contribution to understanding T cell antigen recognition, particularly in the context of cancer immunotherapy, and wider contributions to the immunology community.